You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

DIMETANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dimetane patents expire, and when can generic versions of Dimetane launch?

Dimetane is a drug marketed by Wyeth Cons, Robins Ah, and Wyeth Ayerst. and is included in three NDAs.

The generic ingredient in DIMETANE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIMETANE?
  • What are the global sales for DIMETANE?
  • What is Average Wholesale Price for DIMETANE?
Summary for DIMETANE
US Patents:0
Applicants:3
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 72
Patent Applications: 4,474
DailyMed Link:DIMETANE at DailyMed
Drug patent expirations by year for DIMETANE

US Patents and Regulatory Information for DIMETANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-010 Jun 10, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Robins Ah DIMETANE-DX brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 019279-001 Aug 24, 1984 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-011 Jun 10, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Wyeth Cons DIMETANE brompheniramine maleate TABLET;ORAL 010799-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

DIMETANE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Dimetane

Introduction

Dimetane, a brand name for the antihistamine brompheniramine, is a medication used to relieve symptoms of allergies, hay fever, and the common cold. To understand the market dynamics and financial trajectory of Dimetane, it is crucial to delve into the broader pharmaceutical industry, the role of antihistamines, and the economic factors influencing drug development and sales.

Pharmaceutical Industry Overview

The pharmaceutical industry is a dynamic and highly competitive sector, driven by continuous innovation and the need for new therapeutic options. The industry's growth is fueled by increasing R&D activities, expanding healthcare needs, and advancements in medical technology[3][4].

Role of Antihistamines

Antihistamines, such as Dimetane, play a significant role in managing allergic reactions and other conditions. These drugs are widely used and have a stable demand due to their effectiveness in relieving symptoms of allergies and colds.

Market Drivers for Dimetane

Several factors drive the market for Dimetane and similar antihistamines:

Increasing Demand for Allergy Medications

The prevalence of allergies and respiratory conditions is on the rise, leading to an increased demand for antihistamines. This trend is expected to continue, driven by environmental factors, lifestyle changes, and an aging population.

Expansion of the Pharmaceutical Industry

The pharmaceutical industry is experiencing robust growth, driven by the development of new drugs and therapies. The expansion of this industry directly impacts the demand for antihistamines like Dimetane[4].

R&D Activities

Research and development activities in the pharmaceutical sector are crucial for the introduction of new and improved medications. The development of follow-on or 'me-too' drugs, which often provide additional therapeutic options and inject price competition, is a significant trend in the industry[3].

Financial Trajectory

To understand the financial trajectory of Dimetane, we need to consider several financial and market-related aspects:

Sales and Revenue

The sales of Dimetane and other antihistamines are influenced by the overall performance of the pharmaceutical industry. With the industry expected to grow, the revenue from these medications is likely to increase. For instance, the sales of special pharmaceuticals, including antihistamines, were valued at USD 12.2 billion in 2017, indicating a substantial market size[4].

Competitive Landscape

The pharmaceutical market is highly competitive, with multiple players offering similar products. The competitive nature of the industry drives innovation and price competition, which can impact the financial performance of specific drugs like Dimetane.

Regulatory Environment

Regulatory changes and the period of marketing exclusivity for new drugs can significantly impact the financial trajectory of medications. The period of marketing exclusivity has decreased over time, allowing for quicker entry of follow-on drugs into the market[3].

Key Trends and Innovations

Several trends and innovations are shaping the market for Dimetane and other pharmaceutical products:

Development of New Derivatives

Similar to the dimedone market, where new derivatives are being developed for advanced applications, the pharmaceutical industry is seeing the development of new drug derivatives and formulations. These innovations can enhance the efficacy and safety of antihistamines, potentially increasing their market share[1].

Strategic Partnerships and Mergers

Strategic partnerships and mergers are common in the pharmaceutical industry, facilitating the development of new products and expanding market presence. These collaborations can lead to the introduction of new antihistamines or improved versions of existing ones, such as Dimetane[1].

Technological Advancements

Advancements in technology, including data analysis and drug synthesis, are improving the efficiency and effectiveness of drug development. For example, analyzing large datasets can help in identifying new therapeutic targets and optimizing drug formulations[5].

Economic Factors

Economic factors, such as the cost of production, regulatory costs, and market competition, play a crucial role in the financial trajectory of Dimetane:

Production Costs

The cost of producing antihistamines like Dimetane can be influenced by the availability and cost of raw materials, such as dimedone, which is used in various chemical syntheses[1].

Regulatory Costs

Regulatory costs, including those associated with clinical trials and FDA approvals, can be significant. These costs can impact the pricing and profitability of the drug[3].

Market Competition

Market competition from generic drugs and other antihistamines can affect the pricing and sales volume of Dimetane. The entry of follow-on drugs can lead to price competition, which may reduce the market share of established brands[3].

Conclusion

The market dynamics and financial trajectory for Dimetane are influenced by a combination of factors including the expanding pharmaceutical industry, increasing demand for allergy medications, R&D activities, and economic factors such as production and regulatory costs.

Key Takeaways

  • Increasing Demand: The demand for antihistamines like Dimetane is driven by the rising prevalence of allergies and respiratory conditions.
  • Industry Expansion: The pharmaceutical industry's growth directly impacts the demand for Dimetane.
  • R&D Activities: Continuous R&D activities lead to the development of new and improved medications.
  • Competitive Landscape: The competitive nature of the pharmaceutical market drives innovation and price competition.
  • Economic Factors: Production costs, regulatory costs, and market competition are crucial in determining the financial trajectory of Dimetane.

FAQs

Q: What are the primary drivers of the market for Dimetane? A: The primary drivers include the increasing demand for allergy medications, the expansion of the pharmaceutical industry, and continuous R&D activities.

Q: How does the competitive landscape affect Dimetane? A: The competitive landscape drives innovation and price competition, which can impact the market share and pricing of Dimetane.

Q: What role do regulatory costs play in the financial trajectory of Dimetane? A: Regulatory costs, including those for clinical trials and FDA approvals, can significantly impact the pricing and profitability of Dimetane.

Q: How do technological advancements influence the development of antihistamines like Dimetane? A: Technological advancements in data analysis and drug synthesis improve the efficiency and effectiveness of drug development, potentially leading to new or improved antihistamines.

Q: What is the impact of follow-on drugs on the market for Dimetane? A: Follow-on drugs can lead to price competition and reduce the market share of established brands like Dimetane, but they also provide additional therapeutic options and inject competition into the marketplace.

Sources

  1. Global Dimedone Market Sees Robust Growth Amid Increasing Industrial Applications - Market Research Intellect
  2. Dime Community Bancshares, Inc. Reports Fourth Quarter 2023 Results - Dime Community Bancshares, Inc.
  3. The economics of follow-on drug research and development - PubMed
  4. Ethanol Market Size, Trends, Growth, & Share-2031 - Straits Research
  5. 2022 At A Glance: DimeTyd Achievements from the Past Year - DimeTyd

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.